Connecting the dots...Provectus Biopharmaceuticals
Pages
(Move to ...)
Disclosures
The Blog
Current News
Archived News
Investment and Other Letters
Presentations
Blog Readership Statistics
About the Blogger
▼
Showing posts with label
MD Andersen Cancer Center
.
Show all posts
Showing posts with label
MD Andersen Cancer Center
.
Show all posts
October 23, 2014
More of Better > More or Less of Worse
›
In a February 2013 Cancer Watch article entitled Back to Phase 1: Understanding Systemic Effects of PV-10 , Moffitt Cancer Center's Dr....
July 31, 2014
MD Anderson, More Cash, Checkpoint Protein Inhibitor Combinations
›
MD Anderson surgical oncologist and Provectus principal investigator Dr. Merrick Ross' paper Intralesional therapy with PV-10 (Rose Be...
June 13, 2013
$PVCT is Going for BTD. BTD is Tantamount to Approval.
›
In pursuit of accelerated approval In April 2010 , in response to Provectus' routine request for accelerated approval ("AA...
›
Home
View web version
